+
Site Tour

Search

Showing 61 - 70 of 464 results.

  • TAVI Webinar 2025

    ABBOTT TAVI WEBINARS 2025 Whether you aim at enhancing your skills by joining the advanced TAVI webinars together with P. MacCarthy and a strong pool of experts, or want to capitalize on robust TAV
  • Clinical Data

    SWITCH TO THE REFERRAL VIEW    For more information specific to neurology regarding PFO closure  LEARN MORE: Data summary  PFO Neurology Brochure THE LANDMARK RESPECT TRIAL2S
  • Clinical Data

    SWITCH TO THE REFERRAL VIEW    For more information specific to neonatology regarding PDA closure INTERVENTIONAL DEVICE EXEMPTION AND PICCOLO CLINICAL TRIAL RESULTS CLINICAL CASE REPOR
  • Recommendations

    LEARN MORE: Clinical Trial Summary  EARLY DEVICE INTERVENTION  MODIFIED PDA CLOSURE Early PDA closure can lead to rapid improvement in respiratory status and faster weaning off ventilat
  • CS Webinar 2025

    ABBOTT CS WEBINARS 2025 Join us for our Aortic and Mitral Valve Replacement Webinar Series, where experts will discuss the latest advancements in valvular heart disease management. These sessions w
  • EPIC™ Max Clinical Data

    AT 10 YEARS LEARN MORE: EPIC MAX BROCHURE COMMITED TO VALVE-IN-VALVE* FOLLOW-UP DATA 3-YEAR OUTCOMES OF VALVE-IN-VALVE INTERVENTION IN A U.S. POPULATION Maximizing the internal orifice prov
  • Features

    Silicone-Filled Cuff FlexFitTM Polymer Stent Unique Pericar
  • Guidelines & Recommendations

    2024 EUROPEAN SOCIETY OF CARDIOLOGY (ESC) GUIDELINES FOR THE MANAGEMENT OF ATRIAL FIBRILLATION DEVELOPED IN COLLABORATION WITH THE EUROPEAN ASSOCIATION OF CARDIOTHORACIC SURGERY (EACTS)4-7 ACCESS TO
  • Surgical Replacement

    LEARN MORE: Tissue Heart Valves   Mechanical Heart Valves
  • Overview

    LEARN MORE:​ DIAGNOSIS TREATMENT AS is a progressive disease. While patients with AS may initially be asymptomatic, further progression is typically associated with symptoms and poor pro

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline